Skip to main content
Log in

Inhalation of High Doses of Gaseous Nitric Oxide in HIV Infection

  • MEDICAL BIOPHYSICS
  • Published:
Biophysics Aims and scope Submit manuscript

Abstract

The therapeutic effect of high-dose inhalation of nitrogen oxide gas (at a NO concentration of at least 1000 ppm) in two HIV-infected patients was demonstrated. Inhaled NO therapy led to a rapid decrease in viral load to an undetectable level, which persisted even after the period of analytical interruption of treatment. It was assumed that the relief of HIV infection was due to nitrosonium cations NO+ formed in the blood from neutral NO molecules. The subsequent conversion of NO+ cations in their reaction with hydroxyl anions into nitrite anions was prevented by the binding of NO+ cations with chlorine anions and the formation of nitrosochloride in the blood. The entry of this agent from the blood into cells and tissues provided the transfer of NO+ cations into them. The interaction of nitrosochloride with thiols could lead to the appearance of corresponding S-nitrosothiols in cells and tissues as NO donors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.

REFERENCES

  1. M. R. Bobkova, VICh-infekts. Immunosupressii 12 (1), 22 (2020).

    Google Scholar 

  2. S. Kramer-Hammerle, I. Rothenaigner, H. Wolff, et al., Virus Res. 111, 194 (2005).

    Article  PubMed  Google Scholar 

  3. T.-W. Chun, D. C. Nickle, J. S. Justement, et al., J. Infect. Dis. 197 (5), 714 (2008).

    Article  CAS  PubMed  Google Scholar 

  4. S. Castro-Gonzalez, M. Colomer-Lluch, and R. Serra-Moreno, AIDS Res. Hum. Retroviruses 34 (9), 739 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  5. C. S. Reiss and T. Komatsu, J. Virol. 72 (6), 4547 (1998).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. M. R. Garren, M. Ashcraft, Y. Qian, et al., Appl. Mater. Today 22, 100887 (2021).

  7. F. Lisi, A. N. Zelikin, and R. Chandrawati, Adv. Sci. 8 (7), 2003895 (2021).

  8. F. Sodano, E. Gazzano, R. Fruttero, et al., Molecules 27, 2337 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. T. Persichini, M. Colasanti, M. Fraziano, et al., Biochem. Biophys. Res. Commun. 254, 200 (1999).

    Article  CAS  PubMed  Google Scholar 

  10. J. B. Mannick, J. S. Stamler, E. Teng, et al., J. Acquired Immune Defic. Syndr. 22 (1), 1 (1999).

    Article  CAS  Google Scholar 

  11. T. Persichini, P. Ascenzi, V. Colizzi, et al., Int. J. Mol. Med. 4, 365 (1999).

    CAS  PubMed  Google Scholar 

  12. J. L. Jimenez, J. Gonzalez-Nicolas, S. Alvarez, et al., J. Virol. 75 (10), 4655 (2001).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. D. Torre, A. Pugliese, and F. Speranza, Lancet Infect. Dis. 2, 273 (2002).

    Article  CAS  PubMed  Google Scholar 

  14. E. V. Pechyonkin, A. V. Kovrizhkin, A. V. Pekshev, et al., Biophysics 67 (6), 1023 (2022).

    Article  CAS  PubMed  Google Scholar 

  15. A. F. Vanin, A. V. Pekshev, A. B. Vagapov, et al., Biophysics 66 (1), 155 (2021).

    Article  CAS  PubMed  Google Scholar 

  16. A. F. Vanin, A. V. Pekshev, E. V. Pechenkin, et al., Biophysics 68 (1), 114 (2023).

    Article  CAS  Google Scholar 

  17. J. Z. Li, B. Etemad, H. Ahmed, et al., AIDS 30 (3), 343 (2016).

    CAS  PubMed  Google Scholar 

  18. S. Khan, M. Kayahara, U. Joashi, et al., J. Cell Sci. 110, 2315 (1997).

    Article  CAS  PubMed  Google Scholar 

  19. A. F. Vanin, A. A. Abramov, A. B. Vagapov, et al., Biofizika, 68 (6), 1259 (2023).

  20. A. V. Shipovalov, A. F. Vanin, O. V. P’yankov, et al., Biophysics 67 (5), 785 (2022).

    Article  CAS  PubMed  Google Scholar 

  21. A. F. Vanin, V. A. Tronov, and R. R. Borodulin, Cell Biochem. Biophys. 79, 93 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. A. L. Kleschyov, S. Strand, S. Schmitt, et al., Free Rad. Biol. Med. 40, 1340 (2006).

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

The work was done on an initiative basis. The cost of laboratory tests was paid for by the personal funds of the observed patients and the authors of the article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. F. Vanin.

Ethics declarations

ETHICS APPROVAL AND CONSENT TO PARTICIPATE

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants involved in the study.

CONFLICT OF INTEREST

The authors of this work declare that they have no conflicts of interest.

Additional information

Translated by E. Puchkov

Publisher’s Note.

Pleiades Publishing remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Abbreviations: HIV, human immunodeficiency virus; ART, antiretroviral therapy; PCR, polymerase chain reaction.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pekshev, A.V., Vagapov, A.B., Sharapov, N.A. et al. Inhalation of High Doses of Gaseous Nitric Oxide in HIV Infection. BIOPHYSICS 68, 889–894 (2023). https://doi.org/10.1134/S0006350923050196

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S0006350923050196

Keywords:

Navigation